BillionToOne is a California-based molecular counter platform that provides prenatal screen testing, cancer detection and related solutions for healthcare professionals.
Create an Alert for BillionToOne Jobs
Create a Job Alert
Get notified when new BillionToOne jobs are posted
Do you want to join one of the fastest-growing molecular diagnostics startups and develop products that can affect the lives of millions. BillionToOne. ranked at the top 5% of Y Combinator companies with $300M in funding from prominent VC firms, has developed a DNA molecular counter that increases cfDNA diagnostic resolution by over 1,000 fold. BillionToOne's first product, UNITY™ is the first and only non-invasive prenatal test that can directly...
Do you want to join one of the fastest-growing molecular diagnostics companies to help transform prenatal and oncology diagnostics that can affect millions of patient lives. BillionToOne. ranked at the top 5% of Y Combinator companies with $300M in funding from prominent VC firms, has developed a DNA molecular counter that increases cfDNA diagnostic resolution by over 1,000 fold. BillionToOne's first product, UNITY™ is the first and only non-inva...
Do you want to join one of the fastest-growing molecular diagnostics companies to help transform prenatal and oncology diagnostics that can affect millions of patient lives. BillionToOne. ranked at the top 5% of Y Combinator companies with $300M in funding from prominent VC firms, has developed a DNA molecular counter that increases cfDNA diagnostic resolution by over 1,000 fold. BillionToOne's first product, UNITY™ is the first and only non-inva...
Do you want to join one of the fastest-growing molecular diagnostics companies to help transform prenatal and oncology diagnostics that can affect millions of patient lives. BillionToOne. ranked at the top 5% of Y Combinator companies with $300M in funding from prominent VC firms, has developed a DNA molecular counter that increases cfDNA diagnostic resolution by over 1,000 fold. BillionToOne's first product, UNITY™ is the first and only non-inva...
Do you want to join one of the fastest-growing molecular diagnostics companies to help transform prenatal and oncology diagnostics that can affect millions of patient lives. BillionToOne. ranked at the top 5% of Y Combinator companies with $300M in funding from prominent VC firms, has developed a DNA molecular counter that increases cfDNA diagnostic resolution by over 1,000 fold. BillionToOne's first product, UNITY™ is the first and only non-inva...
Do you want to join one of the fastest-growing molecular diagnostics companies to help transform prenatal and oncology diagnostics that can affect millions of patient lives. BillionToOne. ranked at the top 5% of Y Combinator companies with $300M in funding from prominent VC firms, has developed a DNA molecular counter that increases cfDNA diagnostic resolution by over 1,000 fold. BillionToOne's first product, UNITY™ is the first and only non-inva...
Do you want to join one of the fastest-growing molecular diagnostics companies to help transform prenatal and oncology diagnostics that can affect millions of patient lives. BillionToOne. ranked at the top 5% of Y Combinator companies with $300M in funding from prominent VC firms, has developed a DNA molecular counter that increases cfDNA diagnostic resolution by over 1,000x. BillionToOne's first product, UNITY™, is the first and only non-invasiv...
Do you want to join one of the fastest-growing molecular diagnostics companies to help transform prenatal and oncology diagnostics that can affect millions of patient lives. BillionToOne. ranked at the top 5% of Y Combinator companies with $300M in funding from prominent VC firms, has developed a DNA molecular counter that increases cfDNA diagnostic resolution by over 1,000 fold. BillionToOne's first product, UNITY™ is the first and only non-inva...
Do you want to join one of the fastest-growing molecular diagnostics companies to help transform prenatal and oncology diagnostics that can affect millions of patient lives. BillionToOne. ranked at the top 5% of Y Combinator companies with $300M in funding from prominent VC firms, has developed a DNA molecular counter that increases cfDNA diagnostic resolution by over 1,000 fold. BillionToOne's first product, UNITY™ is the first and only non-inva...
Do you want to join one of the fastest-growing molecular diagnostics startups and develop products that can affect the lives of millions. BillionToOne. ranked at the top 5% of Y Combinator companies with $300M in funding from prominent VC firms, has developed a DNA molecular counter that increases cfDNA diagnostic resolution by over 1,000 fold. BillionToOne's first product, UNITY™ is the first and only non-invasive prenatal test that can directly...
Do you want to join one of the fastest-growing molecular diagnostics startups and develop products that can affect the lives of millions. BillionToOne. ranked at the top 5% of Y Combinator companies with $300M in funding from prominent VC firms, has developed a DNA molecular counter that increases cfDNA diagnostic resolution by over 1,000 fold. BillionToOne's first product, UNITY™ is the first and only non-invasive prenatal test that can directly...
Do you want to join one of the fastest-growing molecular diagnostics startups and develop products that can affect the lives of millions. BillionToOne. ranked at the top 5% of Y Combinator companies with $300M in funding from prominent VC firms, has developed a DNA molecular counter that increases cfDNA diagnostic resolution by over 1,000 fold. BillionToOne's first product, UNITY™ is the first and only non-invasive prenatal test that can directly...
